Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dodick

Showing results (171-180 of 365) with videos related to

Pageof 37
Sort By:
Headache|February 27, 2024
Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experienceNikita Chhabra, Carolyn Mead-Harvey, Christopher A Dodoo, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.
Pain Reports|December 6, 2016
Efficacy of (<i>S</i>)-Lacosamide in preclinical models of cephalic painAubin Moutal, Nathan Eyde, Edwin Telemi, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Cephalalgia : an International Journal of Headache|February 13, 2025
Chronification of migraine sensitizes to CGRP in male and female miceGege Guzman, Caroline M Kopruszinski, Kara R Barber, et al.
Stroke|November 7, 2009
Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhageAaron Izenberg, Richard I Aviv, Bart M Demaerschalk, et al.
Headache|July 3, 2024
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacksRichard B Lipton, Jessica Ailani, Kathleen Mullin, et al.
Cephalalgia : an International Journal of Headache|May 8, 2016
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraineDaniel Fossum Bratbak, Ståle Nordgård, Lars Jacob Stovner, et al.
Clinical Therapeutics|April 28, 2009
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineursDavid W Dodick, Fred Freitag, James Banks, et al.
Pageof 37

Showing results (171-180 of 365) with videos related to

Sort By:
Pageof 37
Headache|February 27, 2024
Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experienceNikita Chhabra, Carolyn Mead-Harvey, Christopher A Dodoo, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.
Pain Reports|December 6, 2016
Efficacy of (<i>S</i>)-Lacosamide in preclinical models of cephalic painAubin Moutal, Nathan Eyde, Edwin Telemi, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Cephalalgia : an International Journal of Headache|February 13, 2025
Chronification of migraine sensitizes to CGRP in male and female miceGege Guzman, Caroline M Kopruszinski, Kara R Barber, et al.
Stroke|November 7, 2009
Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhageAaron Izenberg, Richard I Aviv, Bart M Demaerschalk, et al.
Headache|July 3, 2024
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacksRichard B Lipton, Jessica Ailani, Kathleen Mullin, et al.
Cephalalgia : an International Journal of Headache|May 8, 2016
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraineDaniel Fossum Bratbak, Ståle Nordgård, Lars Jacob Stovner, et al.
Clinical Therapeutics|April 28, 2009
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineursDavid W Dodick, Fred Freitag, James Banks, et al.
Pageof 37